Status | Study |
Completed |
Study Name: Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Myeloid Leukemia in Remission Date: 2013-02-07 Interventions: Drug: vorinostat Given PO |
Recruiting |
Study Name: A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies Condition: Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Date: 2011-06-27 Interventions: Drug: Fludarabine Given IV |
Completed |
Study Name: Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome Condition: Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Date: 2010-07-14 Interventions: Other: flow cytometry Correlat |
Completed |
Study Name: Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia Condition: Childhood Acute Erythroleukemia (M6) Childhood Acute Megakaryocytic Leukemia (M7) Date: 2010-06-16 Interventions: Other: laboratory biomarker analysis Correlative studies |
Completed |
Study Name: Safety and Tolerability Trial of Abatacept-based Immunosuppression for Prevention of Acute Graft Versus Host Disease (aGVHD) During Transplant Condition: AML ALL Undifferentiated Leukemia Date: 2009-11-11 Interventions: Drug: Abatacept Participants will receive one of two standard myeloablative conditioning regimens for th |
Completed |
Study Name: Vaccine Therapy and GM-CSF in Treating Patients With Low-Risk or Intermediate-Risk Myelodysplastic Syndrome Condition: Myelodysplastic Syndromes Date: 2007-08-06 Interventions: Biological: PR1 leukemia peptide vaccine B |
Completed |
Study Name: MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia Condition: Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Megakaryoblastic Leukemia (M7) Date: 2007-04-18 Interventions: Drug: entinostat Given PO |
Active, not recruiting |
Study Name: Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome Condition: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia Wit Date: 2005-07-12 Interventions: Radiation: iodine I 131 monoclonal antibody BC8 |
Completed |
Study Name: Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes Condition: Childhood Myelodysplastic Syndromes de Novo Myelodysplastic Syndromes Date: 2005-03-03 Interventions: Drug: lenalidomide Given orally Other Names: |
Active, not recruiting |
Study Name: Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remissi Date: 2004-03-08 Interventions: Drug: fludarabine phosphate Gi |